KM Financial Solutions | HHS nominee Azar says drug pricing a top priority
4584
post-template-default,single,single-post,postid-4584,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

HHS nominee Azar says drug pricing a top priority

HHS nominee Azar says drug pricing a top priority

WASHINGTON, Nov 29 (Reuters) – Alex Azar, the Republican
nominee to head the U.S. Department of Health and Human Services
and a former Eli Lilly & Co top executive, said on
Wednesday that drug prices are too high and pledged to work on
solutions despite his industry background.

No Comments

Post A Comment